Therini Bio, Inc. is a biotechnology company dedicated to the research and development of novel therapeutics for the treatment of inflammatory diseases due to vascular dysfunction. The current therapeutic target is based on novel findings by the Akassoglou lab at...
Therini Bio, Inc. is a biotechnology company dedicated to the research and development of novel therapeutics for the treatment of inflammatory diseases due to vascular dysfunction. Our lead program is based on novel findings by the Akassoglou lab at Gladstone/UCSF...
Corporate Headquarters Relocated to Lilly Gateway Labs in South San FranciscoNEWS PROVIDED BYTherini Bio, Inc.Feb 24, 2020, 08:17 ET SOUTH SAN FRANCISCO, Calif., Feb. 24, 2020 /PRNewswire/ — MedaRed, Inc., a vascular biology company focused initially on...
Daniel Burgess and Jeffrey Stavenhagen, PhD join leadership team NEWS PROVIDED BY MedaRed, Inc.Jul 08, 2019, 08:00 ET SAN FRANCISCO, July 8, 2019 /PRNewswire/ — MedaRed, Inc., a biotechnology company focused on discovering and developing new therapeutics...
